Galcanezumab-induced fixed drug eruption
Main Authors: | Skylar Klager, SM, Marina Khalil, BS, Kenneth Shulman, MD, Naveed Sami, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512621000485 |
Similar Items
-
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
by: Angelo Camporeale, et al.
Published: (2018-11-01) -
Ustekinumab-induced fixed drug eruption
by: Dhafer M. Hafez, MD, et al.
Published: (2020-12-01) -
A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption
by: Hannah J. Anderson, et al.
Published: (2021-09-01) -
Modafinil-induced Fixed Drug Eruption
by: Girish Vasant Gaikwad, et al.
Published: (2012-01-01) -
A generalized fixed drug eruption associated with mycophenolate
by: Corey Georgesen, MD, et al.
Published: (2017-03-01)